Continue to site >
Trending ETFs

Goldman Sachs Future Health Care Equity ETF

Active ETF
GDOC
Payout Change
Suspended
Price as of:
$34.2527 +0.29 +0.85%
primary theme
N/A
GDOC (ETF)

Goldman Sachs Future Health Care Equity ETF

Payout Change
Suspended
Price as of:
$34.2527 +0.29 +0.85%
primary theme
N/A
GDOC (ETF)

Goldman Sachs Future Health Care Equity ETF

Payout Change
Suspended
Price as of:
$34.2527 +0.29 +0.85%
primary theme
N/A

Name

As of 11/07/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$34.25

$26.1 M

0.00%

0.75%

Vitals

YTD Return

4.7%

1 yr return

18.7%

3 Yr Avg Return

N/A

5 Yr Avg Return

N/A

Net Assets

$26.1 M

Holdings in Top 10

55.1%

52 WEEK LOW AND HIGH

$34.0
$29.71
$37.23

Expenses

OPERATING FEES

Expense Ratio 0.75%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover N/A

Redemption Fee N/A


Min Investment

Standard (Taxable)

N/A

IRA

N/A


Fund Classification

Fund Type

Exchange Traded Fund


Name

As of 11/07/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$34.25

$26.1 M

0.00%

0.75%

GDOC - Profile

Distributions

  • YTD Total Return 4.7%
  • 3 Yr Annualized Total Return N/A
  • 5 Yr Annualized Total Return N/A
  • Capital Gain Distribution Frequency N/A
  • Net Income Ratio N/A
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annual

Fund Details

  • Legal Name
    Goldman Sachs Future Health Care Equity ETF
  • Fund Family Name
    Goldman Sachs Fund Complex
  • Inception Date
    Nov 09, 2021
  • Shares Outstanding
    N/A
  • Share Class
    N/A
  • Currency
    USD
  • Domiciled Country
    US
  • Manager
    Raj Garigipati

Fund Description

The Fund invests, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes (measured at the time of purchase) (“Net Assets”) in equity investments in U.S. and non-U.S. health care companies.Goldman Sachs Asset Management, L.P. (“GSAM” or the “Investment Adviser”) generally defines a health care company as a company in the health care sector. The Investment Adviser may use the classifications assigned by third parties but is not required to do so. The Fund seeks to achieve its investment objective by investing in health care companies that the Investment Adviser believes are driving innovation in health care, by developing either new treatments or new technologies, primarily in the fields of genomics, precision medicine, technology-enabled procedures and digital healthcare. The Investment Adviser seeks to identify companies at various growth stages, including dominant businesses with strong competitive advantages, companies that are early innovators and have developed new treatments or technologies, and companies that are enabling new treatments or technologies that have the potential to disrupt existing markets or serve existing markets more efficiently.Equity investments may include common stock, preferred stock, warrants and other rights to acquire stock, American depositary receipts (“ADRs”), European depositary receipts (“EDRs”), and global depositary receipts (“GDRs”), underlying funds (including exchange-traded funds (“ETFs”)), and futures, forwards, options and other instruments with similar economic exposures. The Fund may invest in companies that only recently began to trade publicly. The Fund may invest in underlying ETFs, exchange-traded products (“ETPs”) and/or money market funds, including those that currently exist or that may become available for investment in the future for which the Investment Adviser or an affiliate now or in the future acts as investment adviser or principal underwriter. The Fund may also invest in unaffiliated ETFs, ETPs and/or money market funds.The Fund generally intends to invest in companies that the Investment Adviser believes are aligned with key themes associated with innovation in health care, which include, but are not limited to, genomics, precision medicine, technology-enabled procedures, and digital healthcare (the “Key Themes”).The Key Themes currently are:Genomics: represents companies that, in the Investment Adviser’s view, provide, invest in or help create products, services or technologies in areas including, but not limited to, sequencing, diagnostic testing and the genomics supply chain.Precision Medicine: represents companies that, in the Investment Adviser’s view, provide, invest in or help create products, services or technologies in areas including, but not limited to, targeted oncology, gene/cell therapy and rare diseases.Technology-Enabled Procedures: represents companies that, in the Investment Adviser’s view, provide, invest in or help create products, services or technologies in areas including, but not limited to, robotic surgery and minimally invasive procedures.Digital Healthcare: represents companies that, in the Investment Adviser’s view, provide, invest in or help create products, services or technologies in areas including, but not limited to, connected devices, digital transformation, and online health.The Key Themes and related areas of investment may change over time at the sole discretion of the Investment Adviser without prior notice to shareholders. In addition, the Fund is permitted to make investments that are not aligned with the Key Themes. In selecting investments, the Investment Adviser will not seek to allocate a specified portion of the Fund’s portfolio to each particular Key Theme, and the allocation of the Fund’s investments across the Key Themes will vary over time in the Investment Adviser’s sole discretion. The Fund may not allocate its investments to each Key Theme at all times and an investment may be aligned with multiple Key Themes at the same time.The Investment Adviser’s belief may be informed by, among other things, company disclosure, third-party research, engagement with the companies, or subjective criteria including the Investment Adviser’s own research, expectations, or opinions. A company in which the Fund invests may not currently or in the future derive any revenue from its association with innovation in health care.The Investment Adviser employs a fundamental investment process that may integrate environmental, social and governance (“ESG”) factors alongside traditional fundamental factors. No one factor or consideration is determinative in the stock selection process.The Fund may invest in foreign securities, including securities of issuers in countries with emerging markets or economies. The Fund may invest without restriction as to company capitalization and may invest significantly in small- and mid-capitalization companies.The Fund concentrates its investments (i.e., holds more than 25% of its total assets) in securities of issuers in the health care industries.THE FUND IS NON-DIVERSIFIED UNDER THE INVESTMENT COMPANY ACT OF 1940, AS AMENDED (THE “INVESTMENT COMPANY ACT”), AND MAY INVEST A LARGER PERCENTAGE OF ITS ASSETS IN FEWER ISSUERS THAN DIVERSIFIED FUNDS.The Fund is an actively managed ETF, which is a fund that trades like other publicly-traded securities. The Fund is not an index fund and does not seek to replicate the performance of a specified index.
Read More

GDOC - Performance

Return Ranking - Trailing

Period GDOC Return Category Return Low Category Return High Rank in Category (%)
YTD 4.7% -25.6% 23.4% 97.77%
1 Yr 18.7% -30.0% 21.8% N/A
3 Yr N/A* -18.7% 19.7% N/A
5 Yr N/A* -14.7% 15.3% N/A
10 Yr N/A* -6.2% 15.7% N/A

* Annualized

Return Ranking - Calendar

Period GDOC Return Category Return Low Category Return High Rank in Category (%)
2023 4.0% -53.9% 11.7% N/A
2022 -17.1% -22.3% 18.5% N/A
2021 N/A -4.7% 41.4% N/A
2020 N/A -10.2% 13.1% N/A
2019 N/A -5.7% 26.9% N/A

Total Return Ranking - Trailing

Period GDOC Return Category Return Low Category Return High Rank in Category (%)
YTD 4.7% -41.2% 23.4% 96.65%
1 Yr 18.7% -30.0% 28.3% N/A
3 Yr N/A* -18.7% 19.7% N/A
5 Yr N/A* -14.7% 15.3% N/A
10 Yr N/A* -6.2% 15.7% N/A

* Annualized

Total Return Ranking - Calendar

Period GDOC Return Category Return Low Category Return High Rank in Category (%)
2023 4.6% -53.9% 11.7% N/A
2022 -17.1% -22.3% 18.5% N/A
2021 N/A -4.7% 41.4% N/A
2020 N/A -10.2% 13.1% N/A
2019 N/A -5.7% 26.9% N/A

GDOC - Holdings

Concentration Analysis

GDOC Category Low Category High GDOC % Rank
Net Assets 26.1 M 732 K 46.2 B 70.49%
Number of Holdings 44 21 473 71.73%
Net Assets in Top 10 13.3 M 2.18 K 21.6 B 67.02%
Weighting of Top 10 55.10% 12.3% 80.8% 71.73%

Top 10 Holdings

  1. Eli Lilly Co 11.63%
  2. AstraZeneca PLC 6.53%
  3. Boston Scientific Corp 6.00%
  4. Novo Nordisk A/S 5.97%
  5. Intuitive Surgical Inc 5.21%
  6. AbbVie Inc 4.63%
  7. Amgen Inc 4.25%
  8. Merck Co Inc 3.89%
  9. Danaher Corp 3.53%
  10. Cooper Cos Inc/The 3.47%

Asset Allocation

Weighting Return Low Return High GDOC % Rank
Stocks
99.07% 85.37% 106.13% 16.75%
Cash
0.93% -0.10% 9.01% 92.67%
Preferred Stocks
0.00% 0.00% 7.86% 61.26%
Other
0.00% -22.99% 3.38% 62.83%
Convertible Bonds
0.00% 0.00% 0.37% 61.26%
Bonds
0.00% 0.00% 12.39% 60.73%

Stock Sector Breakdown

Weighting Return Low Return High GDOC % Rank
Utilities
0.00% 0.00% 0.00% 59.16%
Technology
0.00% 0.00% 22.69% 3.14%
Real Estate
0.00% 0.00% 7.13% 4.19%
Industrials
0.00% 0.00% 7.02% 62.30%
Healthcare
0.00% 59.26% 100.00% 94.76%
Financial Services
0.00% 0.00% 1.85% 72.77%
Energy
0.00% 0.00% 0.00% 59.16%
Communication Services
0.00% 0.00% 9.11% 61.78%
Consumer Defense
0.00% 0.00% 25.73% 62.83%
Consumer Cyclical
0.00% 0.00% 14.20% 61.26%
Basic Materials
0.00% 0.00% 14.83% 71.73%

Stock Geographic Breakdown

Weighting Return Low Return High GDOC % Rank
US
77.62% 53.67% 104.41% 65.45%
Non US
21.45% 0.00% 45.40% 24.61%

GDOC - Expenses

Operational Fees

GDOC Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.75% 0.08% 3.13% 58.76%
Management Fee 0.75% 0.00% 1.25% 66.12%
12b-1 Fee N/A 0.00% 1.00% 18.82%
Administrative Fee N/A 0.03% 0.25% N/A

Sales Fees

GDOC Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 0.00% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

GDOC Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 1.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

GDOC Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover N/A 0.00% 238.00% N/A

GDOC - Distributions

Dividend Yield Analysis

GDOC Category Low Category High GDOC % Rank
Dividend Yield 0.00% 0.00% 2.44% 65.82%

Dividend Distribution Analysis

GDOC Category Low Category High Category Mod
Dividend Distribution Frequency Annual Annually Quarterly Annually

Net Income Ratio Analysis

GDOC Category Low Category High GDOC % Rank
Net Income Ratio N/A -2.54% 1.92% N/A

Capital Gain Distribution Analysis

GDOC Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Annually

Distributions History

View More +

GDOC - Fund Manager Analysis

Managers

Raj Garigipati


Start Date

Tenure

Tenure Rank

Nov 09, 2021

0.56

0.6%

Mr. Garigipati joined the ETF Portfolio Management team in 2015. Mr. Garigipati joined Goldman Sachs in 2003 as a Technology audit analyst in the Internal Audit department covering the Investment Management Division and later was the global audit lead for GSAM before joining the QIS team in 2011 as the Chief Risk Officer. Prior to joining the ETF Portfolio Management team, he had been the Chief Risk Officer of the Quantitative Investment Strategies team since 2011. He joined Goldman Sachs in 2003.

Jenny Chang


Start Date

Tenure

Tenure Rank

Nov 09, 2021

0.56

0.6%

Anant Padmanabhan


Start Date

Tenure

Tenure Rank

Nov 09, 2021

0.56

0.6%

Tenure Analysis

Category Low Category High Category Average Category Mode
0.02 24.72 7.26 2.12